Price Alert

Hong Kong Pharma Digital ... (HKPD)

NASDAQ: HKPD · Real-Time Price · USD

1.25

0.00 (0.00%)

At close: Oct 15, 2025, 3:48 PM

Hong Kong Pharma Digital Technology Statistics

Share Statistics

Hong Kong Pharma Digital Technology has 11M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	11M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	6,468
FTD / Avg. Volume	0.22%

Short Selling Information

The latest short interest is 179.39K, so 1.63% of the outstanding shares have been sold short.

Short Interest	179.39K
Short % of Shares Out	1.63%
Short % of Float	8.9%
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is -360.12 and the forward PE ratio is null. Hong Kong Pharma Digital Technology's PEG ratio is 3.55.

PE Ratio	-360.12
Forward PE	n/a
PS Ratio	0.48
Forward PS	n/a
PB Ratio	1.95
P/FCF Ratio	23.52
PEG Ratio	3.55

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Hong Kong Pharma Digital Technology.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.48.

Current Ratio	2.99
Quick Ratio	2.8
Debt / Equity	0.48
Debt / EBITDA	1.97
Debt / FCF	5.73
Interest Coverage	1.35

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$1.07M
Profits Per Employee	$-1.42K
Employee Count	19
Asset Turnover	2.16
Inventory Turnover	31.96

Taxes

Income Tax	63.17K
Effective Tax Rate	174.92%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 3.49, so Hong Kong Pharma Digital Technology's price volatility has been higher than the market average.

Beta	3.49
52-Week Price Change	n/a
50-Day Moving Average	1.28
200-Day Moving Average	n/a
Relative Strength Index (RSI)	45.94
Average Volume (20 Days)	2,939,767

Income Statement

In the last 12 months, Hong Kong Pharma Digital Technology had revenue of 20.31M and earned -27.06K in profits. Earnings per share was 0.

Revenue	20.31M
Gross Profit	2.42M
Operating Income	132.04K
Net Income	-27.06K
EBITDA	1.21M
EBIT	133.78K
Earnings Per Share (EPS)	0

Full Income Statement

Balance Sheet

The company has 748.72K in cash and 2.37M in debt, giving a net cash position of -1.63M.

Cash & Cash Equivalents	748.72K
Total Debt	2.37M
Net Cash	-1.63M
Retained Earnings	1.5M
Total Assets	9.42M
Working Capital	5.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 569.21K and capital expenditures -154.99K, giving a free cash flow of 414.23K.

Operating Cash Flow	569.21K
Capital Expenditures	-154.99K
Free Cash Flow	414.23K
FCF Per Share	0.05

Full Cash Flow Statement

Margins

Gross margin is 11.89%, with operating and profit margins of 0.65% and -0.13%.

Gross Margin	11.89%
Operating Margin	0.65%
Pretax Margin	0.18%
Profit Margin	-0.13%
EBITDA Margin	5.94%
EBIT Margin	0.65%
FCF Margin	2.04%

Dividends & Yields

HKPD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for HKPD.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	5.02
Piotroski F-Score	4